Polymorphisms of the CD14 Genes are Associated with Susceptibility to Alcoholic Liver Disease in Greek Patients

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 2, 2013, Pages 244-251

  Nezi, Vasiliki ^a   Deutsch, Melanie ^a   Gazouli, Maria ^a   Alexopoulou, Alexandra ^a   Paparrigopoulos, Thomas ^a   Liappas, Ioannis A ^a   Dourakis, Spyros P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alcoholic Liver Disease; CD14; Polymorphisms; Toll Like Receptor 4

Indexed keywords

CD14 ANTIGEN; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; GREECE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ALCOHOLISM; ALLELES; ANTIGENS, CD14; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 84873268545     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2012.01925.x     Document Type: Article

References (40)

1. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191.
2. Barrio E, Tome S, Rodriguez I, Gude F, Sanchez-Leira J, Perez-Becerra E, Gonzalez-Quintela A (2004) Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol Clin Exp Res 28:131-136.
3. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23:1025-1029.
4. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 47:845-850.
5. Bode C, Kugler V, Bode JC (1987) Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4:8-14.
6. Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C (2005) The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res 29:1206-1213.
7. Campos J, Gude F, Quinteiro C, Vidal C, Gonzalez-Quintela A (2006) Gene by environment interaction: the -159C/T polymorphism in the promoter region of the CD14 gene modifies the effect of alcohol consumption on serum IgE levels. Alcohol Clin Exp Res 30:7-14.
8. Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroghs AK (2005) Systematic review: the model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22:1079-1089.
9. Christensen E (2004) Prognostic models including the Child-Pugh, MED and Mayo risk scores-where are we and where should we go? J Hepatol 41:344-350.
10. Corpechot C, Poupon R (2002) Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis. Hepatology 35:242-243.
11. Day CP (2002) CD14 promoter polymorphism associated with risk of NASH. J Hepatol 36(Suppl 1):21.
12. Day CP (2006) Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 26:1021-1028.
13. Eid AJ, Brown RA, Paya CV, Razonable RR (2007) Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 84:511-516.
14. Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG (2005) Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11:681-685.
15. Gleeson D, Bradley MP, Jones J, Peck RJ, Bond SK, Teare MD, Duff GW (2008) Cytokine gene polymorphism in heavy drinkers with and without decompensated liver disease: a case control study. Am J Gastroenterol 103:3039-3046.
16. Grove J, Daly AK, Bassendine MF, Day CP (1997) Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26:143-146.
17. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP (2000) Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 46:540-545.
18. Hoek JB (1999) Endotoxin and alcoholic liver disease: tolerance and susceptibility. Hepatology 29:1602-1604.
19. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KE, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, Mowat NA, Fraumeni JF Jr, El-Omar EM (2007) A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132:905-912.
20. Hrubec Z, Omenn GS (1981) Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 5:207-215.
21. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, Schmitz G (1999) C(-260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99:3218-3220.
22. Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO (2001) Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33:1148-1153.
23. Kamath PS, Kim WR; Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797-805.
24. Kamath PS, Wiesner RN, Malinoch M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470.
25. Leathart J, Day C, Daly A (2001) No association between functional SNPs in the endotoxin receptors CD14 and TLR4 and alcoholic liver disease (ALD): is endotoxin important in the pathogenesis of ALD in humans? Hepatology 34:459A.
26. Le Van TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167:5838-5844.
27. Lukkari TA, Jarvelainen HA, Oinonen T, Kettunen E, Lindros KO (1999) Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol Alcohol 34:311-319.
28. Marcos M, Gόmez-Munuera M, Pastor I, Gonzalez-Sarmiento R, Laso F-J (2009) Tumor necrosis factors polymorphisms and alcoholic liver disease; a HuGE review and meta-analysis. Am J Epidemiol 170:948-956.
29. Martins A, Cortez-Pinto H, Machado M, Gonçalves MS, Soren S, Marques-Vidal P, de Moura MC, Camilo ME (2005) Are genetic polymorphism of tumor necrotic alpha, interleukin-10, CD14 endotoxin receptor or managanese superoxidate dismutase associated with alcoholic liver disease? Eur J Gastroenterol Hepatol 17:1099-1104.
30. Mencin A, Kluwe J, Schwabe RF (2008) Toll-like receptors as targets in chronic liver diseases. Gut 58:704-720.
31. Nagy LE (2003) Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 228:882-890.
32. Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T (1993) Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 142:367-373.
33. O'Halloran AM, Stanton A, O'Brien E, Shields DC (2006) The impact on coronary artery disease of common polymorphisms known to modulate responses to pathogens. Ann Hum Genet 70:934-945.
34. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R, Rodes J (1990) Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 12:1295-1299.
35. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S (2002) Risk factors of fibrosis in alcohol induced liver disease. Hepatology 35:635-638.
36. Riis L, Vind I, Vermeire S, Wolters F, Katsanos K, Politi P, Freitas J, Mouzas IA, O'Morain C, Ruiz-Ochoa V, Odes S, Binder V, Munkholm P, Moum B, Stockbrugger R, Langholz E; European Collaborative Study Group on Inflammatory Bowel Disease (2007) The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis 13:24-32.
37. Stickel F, Hampe J (2011) Genetic determinants of alcoholic liver disease. Gut 61:150-159.
38. Szabo G, Bala S (2010) Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 16:1321-1329.
39. Vercelli D (2002) The functional genomics of CD14 and its role in IgE responses: an integrated view. J Allergy Clin Immunol 109:14-21.
40. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gäbele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, Thurman RG (2001) The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 31:1544-1549.